1-10 of 10
Joel W. Slaton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Prognostic Value of Angiogenesis and Metastasis-related Genes for Progression of Transitional Cell Carcinoma of the Renal Pelvis and Ureter

Keiji Inoue, Masayuki Kamada, Joel W. Slaton, Satoshi Fukata, Chiaki Yoshikawa, Pheroze Tamboli, Colin P. N. Dinney, Taro Shuin
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (6): 1863–1870.
Published: 01 June 2002
View article titled, The Prognostic Value of Angiogenesis and Metastasis-related Genes for Progression of Transitional Cell Carcinoma of the Renal Pelvis and Ureter
Open the PDF for The Prognostic Value of Angiogenesis and Metastasis-related Genes for Progression of Transitional Cell Carcinoma of the Renal Pelvis and Ureter in another window
Journal Articles

Inhibition of Angiogenesis by the Antiepidermal Growth Factor Receptor Antibody ImClone C225 in Androgen-independent Prostate Cancer Growing Orthotopically in Nude Mice

Takashi Karashima, Paul Sweeney, Joel W. Slaton, Sun J. Kim, Daniel Kedar, Jonathan I. Izawa, Zhen Fan, Curtis Pettaway, Daniel J. Hicklin, Taro Shuin, Colin P. N. Dinney
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (5): 1253–1264.
Published: 01 May 2002
View article titled, Inhibition of Angiogenesis by the Antiepidermal Growth Factor Receptor Antibody ImClone C225 in Androgen-independent Prostate Cancer Growing Orthotopically in Nude Mice
Open the PDF for Inhibition of Angiogenesis by the Antiepidermal Growth Factor Receptor Antibody ImClone C225 in Androgen-independent Prostate Cancer Growing Orthotopically in Nude Mice in another window
Journal Articles

Inhibition of Tumorigenicity and Metastasis of Human Bladder Cancer Growing in Athymic Mice by Interferon-β Gene Therapy Results Partially from Various Antiangiogenic Effects Including Endothelial Cell Apoptosis

Jonathan I. Izawa, Paul Sweeney, Paul Perrotte, Daniel Kedar, Zhongyun Dong, Joel W. Slaton, Takashi Karashima, Keji Inoue, William F. Benedict, Colin P. N. Dinney
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (4): 1258–1270.
Published: 01 April 2002
View article titled, Inhibition of Tumorigenicity and Metastasis of Human Bladder Cancer Growing in Athymic Mice by <em>Interferon-β</em> Gene Therapy Results Partially from Various Antiangiogenic Effects Including Endothelial Cell Apoptosis
Open the PDF for Inhibition of Tumorigenicity and Metastasis of Human Bladder Cancer Growing in Athymic Mice by <em>Interferon-β</em> Gene Therapy Results Partially from Various Antiangiogenic Effects Including Endothelial Cell Apoptosis in another window
Journal Articles

Treatment with Low-Dose Interferon-α Restores the Balance between Matrix Metalloproteinase-9 and E-Cadherin Expression in Human Transitional Cell Carcinoma of the Bladder

Joel W. Slaton, Takashi Karashima, Paul Perrotte, Keiji Inoue, Sun J. Kim, Jonathan Izawa, Daniel Kedar, David J. McConkey, Randall Millikan, Paul Sweeney, Chiaki Yoshikawa, Taro Shuin, Colin P. N. Dinney
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (9): 2840–2853.
Published: 01 September 2001
View article titled, Treatment with Low-Dose Interferon-α Restores the Balance between Matrix Metalloproteinase-9 and E-Cadherin Expression in Human Transitional Cell Carcinoma of the Bladder
Open the PDF for Treatment with Low-Dose Interferon-α Restores the Balance between Matrix Metalloproteinase-9 and E-Cadherin Expression in Human Transitional Cell Carcinoma of the Bladder in another window
Journal Articles

The Prognostic Value of Angiogenesis Factor Expression for Predicting Recurrence and Metastasis of Bladder Cancer after Neoadjuvant Chemotherapy and Radical Cystectomy

Keiji Inoue, Joel W. Slaton, Takashi Karashima, Chiaki Yoshikawa, Taro Shuin, Paul Sweeney, Randall Millikan, Colin P. N. Dinney
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (12): 4866–4873.
Published: 01 December 2000
View article titled, The Prognostic Value of Angiogenesis Factor Expression for Predicting Recurrence and Metastasis of Bladder Cancer after Neoadjuvant Chemotherapy and Radical Cystectomy
Open the PDF for The Prognostic Value of Angiogenesis Factor Expression for Predicting Recurrence and Metastasis of Bladder Cancer after Neoadjuvant Chemotherapy and Radical Cystectomy in another window
Journal Articles

Paclitaxel Enhances the Effects of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody ImClone C225 in Mice with Metastatic Human Bladder Transitional Cell Carcinoma

Keiji Inoue, Joel W. Slaton, Paul Perrotte, Darren W. Davis, Christiane J. Bruns, Daniel J. Hicklin, David J. McConkey, Paul Sweeney, Robert Radinsky, Colin P. N. Dinney
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (12): 4874–4884.
Published: 01 December 2000
View article titled, Paclitaxel Enhances the Effects of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody ImClone C225 in Mice with Metastatic Human Bladder Transitional Cell Carcinoma
Open the PDF for Paclitaxel Enhances the Effects of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody ImClone C225 in Mice with Metastatic Human Bladder Transitional Cell Carcinoma in another window
Journal Articles

Gene Therapy of Human Bladder Cancer with Adenovirus-mediated Antisense Basic Fibroblast Growth Factor

Keiji Inoue, Paul Perrotte, Christopher G. Wood, Joel W. Slaton, Paul Sweeney, Colin P. N. Dinney
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (11): 4422–4431.
Published: 01 November 2000
View article titled, Gene Therapy of Human Bladder Cancer with Adenovirus-mediated Antisense Basic Fibroblast Growth Factor
Open the PDF for Gene Therapy of Human Bladder Cancer with Adenovirus-mediated Antisense Basic Fibroblast Growth Factor in another window
Journal Articles

Treatment of Human Metastatic Transitional Cell Carcinoma of the Bladder in a Murine Model with the Anti-Vascular Endothelial Growth Factor Receptor Monoclonal Antibody DC101 and Paclitaxel

Keiji Inoue, Joel W. Slaton, Darren W. Davis, Daniel J. Hicklin, David J. McConkey, Takashi Karashima, Robert Radinsky, Colin P. N. Dinney
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (7): 2635–2643.
Published: 01 July 2000
View article titled, Treatment of Human Metastatic Transitional Cell Carcinoma of the Bladder in a Murine Model with the Anti-Vascular Endothelial Growth Factor Receptor Monoclonal Antibody DC101 and Paclitaxel
Open the PDF for Treatment of Human Metastatic Transitional Cell Carcinoma of the Bladder in a Murine Model with the Anti-Vascular Endothelial Growth Factor Receptor Monoclonal Antibody DC101 and Paclitaxel in another window
Journal Articles

Interleukin 8 Expression Regulates Tumorigenicity and Metastases in Androgen-independent Prostate Cancer

Keiji Inoue, Joel W. Slaton, Beryl Y. Eve, Sun Jin Kim, Paul Perrotte, M. Derya Balbay, Seiji Yano, Menashe Bar-Eli, Robert Radinsky, Curtis A. Pettaway, Colin P. N. Dinney
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (5): 2104–2119.
Published: 01 May 2000
View article titled, Interleukin 8 Expression Regulates Tumorigenicity and Metastases in Androgen-independent Prostate Cancer
Open the PDF for Interleukin 8 Expression Regulates Tumorigenicity and Metastases in Androgen-independent Prostate Cancer in another window
Journal Articles

Interferon-α-mediated Down-Regulation of Angiogenesis-related Genes and Therapy of Bladder Cancer Are Dependent on Optimization of Biological Dose and Schedule

Joel W. Slaton, Paul Perrotte, Keiji Inoue, Colin P. N. Dinney, Isaiah J. Fidler
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (10): 2726–2734.
Published: 01 October 1999
View article titled, Interferon-α-mediated Down-Regulation of Angiogenesis-related Genes and Therapy of Bladder Cancer Are Dependent on Optimization of Biological Dose and Schedule
Open the PDF for Interferon-α-mediated Down-Regulation of Angiogenesis-related Genes and Therapy of Bladder Cancer Are Dependent on Optimization of Biological Dose and Schedule in another window